Taking the correct medicine at the prescribed dose at the right time is a challenge for many people. The solution? A user-friendly medicine-dispensing robot from Evondos, one of Finland’s fastest-growing health tech innovators.
Evondos is committed to solving global health care challenges by delivering safe medication management to greying populations. The company’s focus is on supporting independent living at home while generating cost savings for care organizations.
Having already delivered more than 20 million dispensed medication doses (with over 99% adherence) to clients across the Nordics, today the company is reaching out to partners in global markets, including Japan.
“Globally speaking, I see a phenomenon of a growing elderly population and at the same time, challenges associated with maintaining adequate nursing resources and providing high-quality health care to a growing number of elderly people,” said Evondos CEO Eetu Koski.
“Living longer lives compared with previous generations is great, but comes with many obstacles for the care providers and uncertainty amongst seniors and their families,” he said. “Ensuring secure medication management is the area in which the Evondos medicine-dispensing robot is playing an important role in addressing some of these obstacles.”
The future of pharma
“A significant part of our success is based on our willingness to listen to clients and make investments which lead to hardware and software system innovations to enable world-class usability for the elderly living longer at home,” Koski said.
The Evondos robot serves home-care and elderly clients, and helps professional care organizations by providing secure medicine storage together with spoken, written and indicator light and audio signal guidance when clients are required to take medications. The robot also keeps an electronic log to make clients’ treatment histories available.
“Evondos services and solutions make sure that the right person is given the right medication at the right time. Our solutions ‘free up’ time within a health organization, improve the quality of life for individuals, and offer peace of mind to families and loved ones,” he said.
Evondos in Japan
“We are continuously developing new innovations with an eye on global markets and see huge opportunities to bring Evondos to the Japanese market to serve the country’s aging population,” Koski explained.
“We have taken concrete steps to enter the Japanese market in the near future, as a large number of elderly people in Japan are diagnosed with chronic illness, like memory problems,” Koski said. “Our services, solutions and innovations can be of significant benefit to Japanese clients and we look forward to developing our partnerships with our friends in Japan.”